Stay updated on Mepolizumab in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.

Latest updates to the Mepolizumab in Severe Asthma: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the expected content. The header and footer remain visible, indicating a site access issue rather than a content update.SummaryDifference20%

- Check15 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0 on the page, representing a new version of the page while substantive study details remain unchanged.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates an updated revision of the study record.SummaryDifference0.0%

- Check36 days agoChange DetectedA new publication reference has been added to the study's publications, listing Chen R et al. and the ERJ Open Research article on add-on mepolizumab in severe asthma on medium-dose inhaled corticosteroids (2026 Aug 17;12(4):01652-2025).SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates an internal update to the page while the study details remain unchanged.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a new revision label v3.6.4 replacing the previous v3.6.3. This indicates a version update to the page metadata without visible changes to study content in the provided diffs.SummaryDifference0.0%

Stay in the know with updates to Mepolizumab in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.